![Orin Hirschman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Orin Hirschman
Directeur Général chez AIGH Capital Management LLC
Fortune : 326 566 $ au 30/06/2024
Profil
Orin Zvi Hirschman is currently the Managing Member at AIGH Capital Management LLC and Manager at Aigh Investment Partners LP.
He previously held positions such as President, Chief Executive Officer & Director at Dror Ortho-Design, Inc., Independent Director at Ohr Pharmaceutical, Inc., Principal at LightPath Technologies, Inc., Vice President at 8x8, Inc., Principal at Adam Smith Capital Management LLC, Co-Manager at Adam Smith Investment Partners LP, Principal at D.H.
Blair & Co., Inc., and Co-Manager at Adam Smith Investment Partners, Ltd.
Hirschman received his undergraduate degree from Touro College in 1988 and his MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ARQ, INC.
0,15% | 16/05/2024 | 53 800 ( 0,15% ) | 326 566 $ | 30/06/2024 |
Postes actifs de Orin Hirschman
Sociétés | Poste | Début |
---|---|---|
AIGH Capital Management LLC
![]() AIGH Capital Management LLC Investment ManagersFinance AIGH Capital Management LLC (AIGH) is a SEC-registered investment advisor headquartered in Baltimore, Maryland. The firm was founded in 2011 and is owned by AIGH Investment Partners LLC. AIGH provides discretionary investment advisory services to private investment funds and sub advises private funds. | Directeur Général | - |
Aigh Investment Partners LP
![]() Aigh Investment Partners LP Investment ManagersFinance Aigh Investment Partners LP provides investment advisory services. The company was incorporated in 2011 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | 01/01/2011 |
Anciens postes connus de Orin Hirschman
Sociétés | Poste | Fin |
---|---|---|
Ohr Pharmaceutical, Inc.
![]() Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 12/07/2019 |
Adam Smith Capital Management LLC
![]() Adam Smith Capital Management LLC Investment ManagersFinance Adam Smith Capital Management LLC is a private equity firm headquartered in New York City | Corporate Officer/Principal | 01/01/2002 |
D.H. Blair & Co., Inc. | Corporate Officer/Principal | 31/03/1988 |
Adam Smith Investment Partners, Ltd. | Corporate Officer/Principal | - |
Adam Smith Investment Partners LP
![]() Adam Smith Investment Partners LP Investment ManagersFinance Adam Smith Investment Partners LP is a company that acts as a private equity fund. The company is based in New York, NY. | Corporate Officer/Principal | - |
Formation de Orin Hirschman
Touro College | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
8X8, INC. | Technology Services |
LIGHTPATH TECHNOLOGIES, INC. | Electronic Technology |
DROR ORTHO-DESIGN, INC. | Electronic Technology |
Entreprise privées | 7 |
---|---|
Adam Smith Capital Management LLC
![]() Adam Smith Capital Management LLC Investment ManagersFinance Adam Smith Capital Management LLC is a private equity firm headquartered in New York City | Finance |
AIGH Capital Management LLC
![]() AIGH Capital Management LLC Investment ManagersFinance AIGH Capital Management LLC (AIGH) is a SEC-registered investment advisor headquartered in Baltimore, Maryland. The firm was founded in 2011 and is owned by AIGH Investment Partners LLC. AIGH provides discretionary investment advisory services to private investment funds and sub advises private funds. | Finance |
Ohr Pharmaceutical, Inc.
![]() Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
D.H. Blair & Co., Inc. | |
Aigh Investment Partners LP
![]() Aigh Investment Partners LP Investment ManagersFinance Aigh Investment Partners LP provides investment advisory services. The company was incorporated in 2011 and is headquartered in Baltimore, MD. | Finance |
Adam Smith Investment Partners LP
![]() Adam Smith Investment Partners LP Investment ManagersFinance Adam Smith Investment Partners LP is a company that acts as a private equity fund. The company is based in New York, NY. | Finance |
Adam Smith Investment Partners, Ltd. |